Home

1.Ocrelizumab - 300 mg/10 ml

Deadline:23 Mar 2025, 23:00 UTC

Tender information

TED EU

Skoplje, North Macedonia

Type
20
Procedure
open
Ref. number
114482-2025
CPV
33600000

lijekovi za liječenje multiple skleroze

Show all tender information

Documents

Show all important dates